查看文章

We have read with interest the article by Lewis White and Colleagues, providing insights on invasive fungal infections in COVID-19 patients [1]. The Authors describe a significant proportion of invasive yeast infections, especially candidemia. It is not clear to date if the incidence of candidemia in COVID-19 patients is higher than expected. Moreover, no comparison of clinical presentation and outcomes between affected patients with and without COVID-19 is available.